Choice of basal insulin therapy is associated with weight and height development in type 1 diabetes: A multicenter analysis from the German/Austrian DPV registry in 10 338 children and adolescents.

Heike VollbachMarie AuzanneauThomas ReinehrSusanna WiegandKarl-Otfried SchwabRudolf OeverinkElke Froehlich-ReitererJoachim WoelfleCarine De BeaufortThomas KapellenBettina GohlkeReinhard W Holl

Published in: Journal of diabetes (2021)

Choice of basal insulin regimen might influence height development. CSII appeared to have a favorable effect on growth trajectories. All therapies were associated with an increase of BMI-SDS, most evident in females.

Keyphrases

type diabetes
body mass index
glycemic control
weight gain
physical activity
cardiovascular disease
depressive symptoms
stem cells
decision making
clinical trial
cross sectional
adipose tissue
bone marrow
skeletal muscle
metabolic syndrome
body weight